Literature DB >> 18840880

Chagas cardiomyopathy: Europe is not spared!

Roberto A Guerri-Guttenberg1, Daniel R Grana, Giuseppe Ambrosio, José Milei.   

Abstract

Entities:  

Mesh:

Year:  2008        PMID: 18840880     DOI: 10.1093/eurheartj/ehn424

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


× No keyword cloud information.
  19 in total

1.  Arylimidamide DB766, a potential chemotherapeutic candidate for Chagas' disease treatment.

Authors:  Denise da Gama Jaén Batista; Marcos Meuser Batista; Gabriel Melo de Oliveira; Patrícia Borges do Amaral; Joseli Lannes-Vieira; Constança Carvalho Britto; Angela Junqueira; Marli Maria Lima; Alvaro José Romanha; Policarpo Ademar Sales Junior; Chad E Stephens; David W Boykin; Maria de Nazaré Correia Soeiro
Journal:  Antimicrob Agents Chemother       Date:  2010-05-10       Impact factor: 5.191

Review 2.  Chagas disease and transfusion medicine: a perspective from non-endemic countries.

Authors:  Andrea Angheben; Lucia Boix; Dora Buonfrate; Federico Gobbi; Zeno Bisoffi; Simonetta Pupella; Giorgio Gandini; Giuseppe Aprili
Journal:  Blood Transfus       Date:  2015-10       Impact factor: 3.443

3.  In vitro and in vivo biological effects of novel arylimidamide derivatives against Trypanosoma cruzi.

Authors:  Bruno Lisboa Timm; Patrícia Bernadino da Silva; Marcos Meuser Batista; Francisca Hildemagna Guedes da Silva; Cristiane França da Silva; Richard R Tidwell; Donald A Patrick; Susan Kilgore Jones; Stanislav A Bakunov; Svetlana M Bakunova; Maria de Nazaré C Soeiro
Journal:  Antimicrob Agents Chemother       Date:  2014-04-21       Impact factor: 5.191

4.  [Cardiac manifestations of tropical diseases].

Authors:  C Kraef; M Ramharter
Journal:  Herz       Date:  2019-02       Impact factor: 1.443

Review 5.  Chronic Chagas' heart disease: a disease on its way to becoming a worldwide health problem: epidemiology, etiopathology, treatment, pathogenesis and laboratory medicine.

Authors:  Silvia Gilka Muñoz-Saravia; Annekathrin Haberland; Gerd Wallukat; Ingolf Schimke
Journal:  Heart Fail Rev       Date:  2012-01       Impact factor: 4.214

6.  Validation of a rapid immunochromatographic assay for diagnosis of Trypanosoma cruzi infection among Latin-American Migrants in Geneva, Switzerland.

Authors:  François Chappuis; Anne Mauris; Marylise Holst; Pedro Albajar-Vinas; Jean Jannin; Alejandro O Luquetti; Yves Jackson
Journal:  J Clin Microbiol       Date:  2010-06-16       Impact factor: 5.948

7.  Prevalence, clinical staging and risk for blood-borne transmission of Chagas disease among Latin American migrants in Geneva, Switzerland.

Authors:  Yves Jackson; Laurent Gétaz; Hans Wolff; Marylise Holst; Anne Mauris; Aglaé Tardin; Juan Sztajzel; Valérie Besse; Louis Loutan; Jean-Michel Gaspoz; Jean Jannin; Pedro Albajar Vinas; Alejandro Luquetti; François Chappuis
Journal:  PLoS Negl Trop Dis       Date:  2010-02-02

Review 8.  Epidemiology of Chagas disease in Europe: many calculations, little knowledge.

Authors:  Jörn Strasen; Tatjana Williams; Georg Ertl; Thomas Zoller; August Stich; Oliver Ritter
Journal:  Clin Res Cardiol       Date:  2013-08-29       Impact factor: 5.460

9.  Global economic burden of Chagas disease: a computational simulation model.

Authors:  Bruce Y Lee; Kristina M Bacon; Maria Elena Bottazzi; Peter J Hotez
Journal:  Lancet Infect Dis       Date:  2013-02-08       Impact factor: 25.071

10.  Prevalence of Chagas heart disease in dilated cardiomyopathy.

Authors:  Héctor González-Zambrano; Gerardo Amaya-Tapia; María C Franco-Ramos; Oscar J López León-Murguía
Journal:  Arch Cardiol Mex       Date:  2020-10-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.